No Longer Available EXPANDED_ACCESS NCT05541289
Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older
An Intermediate Size Expanded Access Program of Whole, Inactivated SARS-CoV-2 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older
Sponsor: Ocugen
Conditions
COVID-19
Interventions
BBV152
Updated 3 times since 2022 Last updated: Sep 20, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on COVID-19, this trial is ongoing. The trial is conducted by Ocugen and has accumulated 3 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Sep 2022 — Jul 2024 [monthly]
No Longer Available
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ocugen
Data source: Ocugen
For direct contact, visit the study record on ClinicalTrials.gov .